Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8454482 | Lung Cancer | 2016 | 6 Pages |
Abstract
The prevalence of RET fusion is approximately 1.8% in Chinese patients with lung adenocarcinoma. RET rearrangements are characterized by lepidic predominance and a lower TS level. RET-rearranged patients may benefit more from pemetrexed-based regimen.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zhengbo MD, Xinmin Yu, Yiping MD,